Recombinant IL21 (Avizakimab Biosimilar) 抗体
-
- 抗原 See all IL21 (Avizakimab Biosimilar) products
- IL21 (Avizakimab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- 人
-
宿主
-
Human
- Expression System
- CHO Cells
-
克隆类型
- 单克隆
-
标记
- This IL21 (Avizakimab Biosimilar) antibody is un-conjugated
- 应用范围
- ELISA, Surface Plasmon Resonance (SPR), Functional Studies (Func), Flow Cytometry (FACS), Bio-Layer Interferometry (BLI)
- 原理
- Anti-IL-21 Reference Antibody (avizakimab)
- 序列
- QVQLVQSGAE VKKPGASVKV SCKASGYTFT DYWMHWVRQA PGQGLEWMGT IDPSDQYTIY SQNFKGRVTM TRDTSTSTVY MELSSLRSED TAVYYCARYG FAMDYWGQGT LVTVSSASTK GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKRVEPKSCD KTHTCPPCPA PELLGGPSVF LFPPKPKDTL YITREPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSREEMTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGK,DIQLTQSPSS LSASVGDRVT ITCRASQDIS NFLNWYQQKP GKAVKLLIYY TSRLHSGVPS RFSGSGSGTD YTLTISSLQP EDFATYYCQQ GHTLPRTFGG GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
- 产品特性
- Anti-IL-21 Reference Antibody (avizakimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
- 纯度
- >95 %
- 亚型
- IgG1
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 说明
-
Therapeutic Agents by Target and Mechanism: IL-21 inhibitors
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 浓度
- 1 mg/mL
- 缓冲液
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
- 储存条件
- 4 °C,-80 °C
- 储存方法
- +4°C,-80°C
-
- 抗原
- IL21 (Avizakimab Biosimilar)
- 别名
- IL-21 (Avizakimab Biosimilar) (IL21 (Avizakimab Biosimilar) 产品)
- 物质类
- Biosimilar
- 分子量
- 145.5 kDa
- UniProt
- Q9HBE4
-